Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms
Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ combines pulsed field ablation (PFA) and radiofrequency (RF) energy in a single catheter to treat complex atrial fibrillation (AFib) cases Strong clinical evidence demonstrates the device's high rates of safety and effectiveness...
Covered in this story
What has happened since
- Regions Financial Corporation is down 7.4% since this was published, 42 days ago.
- Abbott Laboratories is down 2.9% since this was published, 42 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Regions Financial Corporation
- Baird: $28.5 → $28 by Sep 2027 · Neutral via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $RF yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Regions Financial Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.